All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results | 2004-002474-36 | Observer blinded, randomized Phase III study to investigate the non-inferiority of IC51 (JE-PIV) vs. JE-VAX as vaccines for japanese encephalitis in healthy volunteers | 2006-03-17 | due-trials |
| Reported results | 2004-005072-17 | PHASE 3 STUDY TO COMPARE A RAPID IMMUNIZATION REGIME WITH THE STANDARD REGIME FOR IC51 (JE-PIV) AS VACCINE FOR JAPANESE ENCEPHALITIS | 2006-02-06 | due-trials |
| Reported results | 2005-000100-14 | Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study | 2006-03-07 | due-trials |
| Reported results | 2005-000253-29 | LONG TERM IMMUNOGENICITY OF THE JAPANESE ENCEPHALITIS VACCINE IC51 (JE-PIV). AN UNCONTROLLED PHASE 3 FOLLOW-UP STUDY | 2011-03-25 | due-trials |
| Reported results | 2005-000593-41 | Long term persistence and effect of a booster dose of the Japanese encephalitis vaccine IC51 (JE-PIV). | 2007-11-26 | due-trials |
| Completed, but no date, and reported results | 2005-003526-25 | Safety and immunogenicity of concomitant vaccination with IC51 and Havrix 1440 in healthy subjects. A single-blind randomised, controlled phase 3 study. | bad-data | |
| Reported results | 2006-002034-37 | OPEN-LABEL, MULTICENTER TRIAL WITH IC41, A THERAPEUTIC HCV VACCINE IN PATIENTS WITH CHRONIC HCV | 2009-02-28 | due-trials |
| Reported results | 2006-002076-18 | COMPARISON OF THREE BATCHES OF THE JAPANESE ENCEPHALITIS VACCINE IC51 (JE-PIV). DOUBLE BLIND, RANDOMIZED, CONTROLLED PHASE 3 STUDY. | 2007-04-20 | due-trials |
| Reported results | 2007-002771-14 | COMPARISON OF THREE COMMERCIAL BATCHES OF THE JAPANESE ENCEPHALITIS VACCINE IC51. DOUBLE BLIND, RANDOMIZED, CONTROLLED PHASE 3 STUDY | 2008-02-25 | due-trials |
| Reported results | 2007-002793-64 | EFFECT OF A BOOSTER DOSE OF THE JAPANESE ENCEPHALITIS VACCINE IC51 ON LONG TERM IMMUNOGENICITY. AN UNCONTROLLED, OPEN-LABEL PHASE 3 STUDY. | 2009-02-16 | due-trials |
| Reported results | 2008-004634-24 | IMMUNOGENICITY OF A COMMERCIAL BATCH OF THE JAPANESE ENCEPHALITIS VACCINE IC51 UP TO TWENTY-FOUR MONTHS POST FILLING, OPEN-LABEL, MULTICENTER, PHASE 3 STUDY | 2010-10-31 | due-trials |
| Reported results | 2008-005037-30 | "FASE 2 DEL ESTUDIO PILOTO, QUE EVALUA LA INMUNOGENICIDAD Y LA SEGURIDAD DE IC43 EN PACIENTES EN LA UNIDAD DE CUIDADOS INTENSIVOS" Original title: "A PHASE 2 PILOT STUDY ASSESSING IMMUNOGENICITY AND ... | 2010-02-26 | due-trials |
| Reported results | 2008-008726-75 | A Phase Three, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of the Travelers’ Diarrhea Vaccine System | 2011-04-12 | due-trials |
| Trial is outside EEC, and reported results | 2009-015588-15 | SAFETY AND IMMUNOGENICITY OF THE JAPANESE ENCEPHALITIS VACCINE IC51 (IXIARO®) IN A PEDIATRIC POPULATION. OPEN LABEL, RANDOMIZED, ACTIVE CONTROLLED, PHASE 3 STUDY | bad-data | |
| Reported results | 2009-015595-10 | IMMUNOGENICITY AND SAFETY OF THE JAPANESE ENCEPHALITIS VACCINE IC51 (IXIARO®, JESPECT®) IN A PEDIATRIC POPULATION IN NON‐ENDEMIC COUNTRIES. UNCONTROLLED, OPEN‐LABEL PHASE 3 STUDY | 2013-08-09 | due-trials |
| Reported results | 2009-015603-10 | A Phase Two, Multicenter, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of the Travelers' Diarrhea Vaccine System in Travelers to Asia | 2010-12-16 | due-trials |
| Reported results | 2010-018630-52 | AN OPEN-LABEL, UNCONTROLLED PHASE 4 STUDY TO ASSESS THE SAFETY AND IMMUNOGENICITY OF THE JAPANESE ENCEPHALITIS (JE) VACCINE IXIARO® (IC51) IN AN ELDERLY POPULATION | 2011-10-11 | due-trials |
| Trial is outside EEC, and reported results | 2010-022265-10 | LONG TERM IMMUNITY AND SAFETY WITH OR WITHOUT A BOOSTER DOSE FOLLOWING PRIMARY VACCINATION WITH THE JAPANESE ENCEPHALITIS VACCINE IC51 (IXIARO®) IN A PEDIATRIC POPULATION IN A JEV-ENDEMIC COUNTRY. OP... | bad-data | |
| Reported results | 2011-004771-36 | A CONFIRMATORY PHASE II/III STUDY ASSESSING EFFICACY, IMMUNOGENICITY AND SAFETY OF IC43 RECOMBINANT PSEUDOMONAS VACCINE IN INTENSIVE CARE PATIENTS. | 2015-12-29 | due-trials |